Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO

NCT06792643 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Cardiogenic Shock
Extracorporeal Membrane Oxygenation Complication
Platelet Dysfunction

Interventions

DRUG: Cangrelor

Sponsor

IRCCS San Raffaele